232 related articles for article (PubMed ID: 21617786)
1. [Extravasation of cytostatic drugs].
Pikó B; Puskásné Szatmári K; Bassam A; Csiffári M; Dimák S; Szabó Z; Ocsai H; Csotye J
Magy Onkol; 2011 Mar; 55(1):4-13. PubMed ID: 21617786
[TBL] [Abstract][Full Text] [Related]
2. [Introduction of a clinical protocol for extravasation at the National Institute of Oncology, Budapest, Hungary].
Bartal A; Mátrai Z; Rosta A; Szûcs A
Magy Onkol; 2011 Mar; 55(1):14-20. PubMed ID: 21617787
[TBL] [Abstract][Full Text] [Related]
3. [Extravasation of chemotherapeutic agents: prevention and therapy].
Jordan K; Grothe W; Schmoll HJ
Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
[TBL] [Abstract][Full Text] [Related]
4. European Oncology Nursing Society extravasation guidelines.
Wengström Y; Margulies A;
Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
[TBL] [Abstract][Full Text] [Related]
5. [The significance of extravasation in oncological care].
Zatkóné Puskás G
Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
[TBL] [Abstract][Full Text] [Related]
6. Management of the extravasation of anti-neoplastic agents.
Boulanger J; Ducharme A; Dufour A; Fortier S; Almanric K; ;
Support Care Cancer; 2015 May; 23(5):1459-71. PubMed ID: 25711653
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic vesicant extravasation.
Beason R
J Intraven Nurs; 1990; 13(2):111-4. PubMed ID: 2313459
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of perivascular extravasation of cytostatic agents].
Rauh J; Pluntke S; Müller Ch
MMW Fortschr Med; 2004 Aug; 146(31-32):23-4, 26-7. PubMed ID: 15529703
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
[TBL] [Abstract][Full Text] [Related]
10. Infiltration and extravasation.
Schulmeister L
Am J Nurs; 2007 Oct; 107(10):16. PubMed ID: 17895711
[No Abstract] [Full Text] [Related]
11. IV vesicants: how to avoid extravasation.
Wood LS; Gullo SM
Am J Nurs; 1993 Apr; 93(4):42-6. PubMed ID: 8480802
[No Abstract] [Full Text] [Related]
12. Managing vesicant extravasations.
Schulmeister L
Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
[TBL] [Abstract][Full Text] [Related]
13. Developing extravasation protocols and monitoring outcomes.
Camp-Sorrell D
J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
[TBL] [Abstract][Full Text] [Related]
14. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
15. Prevention and management of extravasation of cytotoxic drugs.
Bertelli G
Drug Saf; 1995 Apr; 12(4):245-55. PubMed ID: 7646823
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
17. Extravasation management.
Schulmeister L
Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
[TBL] [Abstract][Full Text] [Related]
18. [Cytostatic drug extravasation--are there new recommendations for therapeutic management?].
Fenchel K; Karthaus M
Wien Med Wochenschr; 2001; 151(3-4):44-6. PubMed ID: 11789418
[TBL] [Abstract][Full Text] [Related]
19. [The extravasation of cytostatic drugs: its diagnosis, evolution and treatment].
Llop JC; Mateu J; Llorente A
Med Clin (Barc); 1993 Jun; 101(3):105-9. PubMed ID: 8315981
[No Abstract] [Full Text] [Related]
20. [Extravasation of cytotoxic agents].
Nogler-Semenitz E; Mader I; Fürst-Weger P; Terkola R; Wassertheurer S; Giovanoli P; Mader RM
Wien Klin Wochenschr; 2004 May; 116(9-10):289-95. PubMed ID: 15237653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
